Participation of D1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe6 angiotensin IV

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 3, 2010, Pages 343-350

  Braszko, Jan J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiotensins; Behavior; Dopamine; Memory; Postsynaptic receptors; Presynaptic receptors; Rat

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-7]; ANGIOTENSIN II [3-8]; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMIC ACID; NAFADOTRIDE; REMOXIPRIDE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; AVOIDANCE BEHAVIOR; COGNITION; HUMAN; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SPATIAL MEMORY; STIMULUS RESPONSE; TISSUE SPECIFICITY;

ANGIOTENSIN II; ANIMALS; BRAIN; COGNITION; HUMANS; NOOTROPIC AGENTS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4;

EID: 72449122792     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.08.001     Document Type: Review

References (106)

1. Ader R., Weijnen J.A.W.M., and Moleman P. Retention of a passive avoidance responses as a function of the intensity and duration of electric shock. Psychon. Sci. 26 (1972) 125-129
2. Aggleton J.P., Kyd R.J., and Bilkey D.K. When is the perirhinal cortex necessary for the performance of spatial memory tasks?. Neurosci. Biobehav. Rev. 28 (2004) 611-624
3. Albensi B.C. The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitoxicity. Curr. Pharm. Des. 13 (2007) 3185-3194
4. 4) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276 (2001) 48623-48626
5. Allen A.M., MacGregor D.P., Chai S.Y., Donnan G.A., Kaczmarczyk S., Richardson K., Kalnis R., Ireton J., and Mendelsohn F.A. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann. Neurol. 32 (1992) 339-344
6. Allen A.M., Moeller I., Jenkins T.A., Zhuo J., Aldred G.P., Chai S.Y., and Mendelsohn F.A.O. Angiotensin receptors in the nervous system. Brain Res. Bull. 47 (1998) 17-28
7. Baranowska D., Braszko J.J., and Wiśniewski K. Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology 81 (1983) 247-251
8. Becker K., Laucht M., El-Faddagh M., and Schmidt M.H. The dopamine D4 receptor gene exon III polymorphism is associated with novelty seeking in 15-year-old males from a high-risk community sample. J. Neural. Transm. 112 (2005) 847-858
9. Bernaerts P., and Tirelli E. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice. Behav. Brain Res. 142 (2003) 41-52
10. Borland L.M., and Michael A.C. Voltammetric study of the control of striatal dopamine release by glutamate. J. Neurochem. 91 (2004) 220-229
11. Braszko J. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects. Acta Neurobiol. Exp. 56 (1996) 49-54
12. 6 angiotensin IV. Peptides 25 (2004) 1195-1203
13. 6 Ang IV. Physiol. Behav. 88 (2006) 152-159
14. 6-Ang IV in rats. Eur. Neuropsychopharm. 19 (2009) 85-91
15. Braszko J.J., Kułakowska A., and Winnicka M.M. Effects of angiotensin II and its receptor antagonists on motor activity and anxiety in rats. J. Physiol. Pharmacol. 54 (2003) 271-281
16. Braszko J.J., Kupryszewski G., Witczuk B., and Wiśniewski K. Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and conditioned avoidance responses in rats. Neuroscience 27 (1988) 777-783
17. Braszko J.J., Walesiuk A., and Wielgat P. Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV. JRAAS 7 (2006) 168-174
18. 3 dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. Neuropeptides 42 (2008) 301-309
19. Braszko J., and Wiśniewski K. Effect of angiotensin on the central action of dopamine. Pol. J. Pharmacol. Pharm. 28 (1976) 667-672
20. Braszko J.J., and Wiśniewski K. Effect of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats. Peptides 9 (1988) 475-479
21. Braszko J.J., and Wiśniewski K. Participation of the N-methyl-d-aspartate receptors in memory improving effects of angiotensin II(3-7). Pharmacol. Res. 31 Suppl. (1995) 260
22. Braszko J.J., Wiśniewski K., Kupryszewski G., and Witczuk B. Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour. Behav. Brain Res. 25 (1987) 195-203
23. Braszko J.J., Własienko J., Koziołkiewicz W., Janecka A., and Wiśniewski K. The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res. 542 (1991) 49-54
24. 1 receptor in vitro and in vivo. Br. J. Pharmacol. 118 (1996) 414-420
25. Carr G.D., and White N.M. The relationship between stereotypy and memory improvement produced by amphetamine. Psychpharmacology 82 (1984) 203-209
26. Chai S.Y., Bastias M.A., Clune E.F., Matsacos D.J., Mustafa T., Lee J.H., McDowall S.G., Paxinos G., Mendelsohn F.A., and Albiston A.L. Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J. Chem. Neuroanat. 20 (2000) 339-348
27. 4 receptor. Cell. Mol. Life Sci. 61 (2004) 2728-2737
28. Chai S.Y., Yeatman H.R., Parker M.W., Ascher D.B., Thompson P.E., Mulvey H.T., and Albiston A.L. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase. BMC Neurosci. 9 Suppl. 2 (2008) S14 doi: 10.1186/1471-2202-9-S2-S14
29. Chang Q., and Gold P.E. Switching memory systems during learning: changes in patterns of brain acetylcholine release in the hippocampus and striatum in rats. J. Neurosci. 23 (2003) 3001-3005
30. Chávez-Martínez M.E., Reyes-Vázquez C., and Brust-Carmona H. Lever pressing and active avoidance conditioning after electrolytic lesions of the entopenduncular nucleus in cats. Brain Res. Bull. 18 (1987) 279-284
31. Cohn J.N., and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345 (2001) 1667-1675
32. Corominas-Roso M., Roncero C., Bruguera E., and Casas M. Sistema dopaminérgico y adicciones. Rev. Neurol. 44 (2007) 23-31
33. Dale R.H.I., and Innis N.K. Interactions between response stereotypy and memory strategies on the eight-arm radial maze. Behav. Brain Res. 19 (1986) 17-25
34. David H.N., Ansseeu M., and Abraini J.H. Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res. Rev. 50 (2005) 336-360
35. 4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-d-aspartate dependent form of long-term potentiation. Neuroscience 137 (2006) 1369-1379
36. de Bundel D., Smolders I., Vanderheyden P., and Michotte Y. Ang II and Ang IV: unravelling the mechanism of action on synaptic plasticity, memory, and epilepsy. CNS Neurosci. Ther. 14 (2008) 315-339
37. de Leonibus E., Oliveiro A., and Mele A. A study on the role of the dorsal striatum and the nucleus accumbens in allocentric and egocentric spatial memory consolidation. Learn. Mem. 12 (2005) 491-503
38. Decker M.W., and McGaugh J.L. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7 (1991) 151-168
39. 125I]Ang IV binding and catalytic activity. Biochem. Pharmacol. 68 (2004) 885-892
40. Duncan A.M., James G.M., Anastasopoulos F., Kladis A., Briscoe T.A., and Campbell D.J. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. J. Pharmacol. Exp. Ther. 289 (1999) 295-303
41. El-Ghundi M., O'Dowd B.F., and George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18 (2007) 37-66
42. Ennaceur A., and Meliani K. A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs nonspatial working memory. Behav. Brain Res. 51 (1992) 83-92
43. Girault J.A., and Greengard P. The neurobiology of dopamine signalling. Arch. Neurol. 61 (2004) 641-644
44. Gold P.E. Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol. Learn. Mem. 80 (2003) 194-210
45. 1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 174 (2004) 3-16
46. Handa R.K. Characterization and signaling of the AT(4) receptor in human proximal tubule epithelial (HK-2) cells. J. Am. Soc. Nephrol. 12 (2001) 440-449
47. Hołownia A., and Braszko J.J. The effect of angiotensin II and IV on ERK1/2 and CREB signaling in cultured rat astroglial cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 376 (2007) 157-163
48. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 69 (2003) 375-390
49. Kesner R.P., Bolland B.L., and Dakis M. Memory for spatial locations, motor responses, and objects: triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Exp. Brain Res. 93 (1993) 462-470
50. Kuntsi J., McLoughlin G., and Asherson P. Attention deficit hyperactivity disorder. Neuromol. Med. 8 (2006) 461-484
51. Le M.T., Vanderheyden P.M.L., Szaszak M., Hunyady L., and Vauquelin G. Angiotenisin IV is a potent agonist for constitutive active human AT1 receptors: distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation. J. Biol. Chem. 277 (2002) 23107-23110
52. Levin E.D., McGurk S.R., Rose J.E., and Butcher L.L. Cholinergic-dopaminergic interactions in cognitive performance. Behav. Neural. Biol. 54 (1990) 271-299
53. Liang K.C., McGaugh J.L., Martinez J.L., Jensen R.A., Vasquez B.J., and Messing R.B. Post-training amygdaloid lesions impair retention of an inhibitory avoidance response. Behav. Brain Res. 4 (1982) 237-249
54. Malik P., Andersen M.B., and Peacock L. The effects of dopamine agonists and antagonists in a nonhuman primate model of tardive dyskinesia. Pharmacol. Biochem. Behav. 78 (2004) 805-810
55. Mansour A., and Watson S.J. Dopamine receptor expression in the central nervous system. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 207-219
56. Mastick C.C., Aebersold R., and Lienhard G.E. Characterization of a major protein in GLUT4 vesicles. Concentration in the vesicles and insulin-stimulated translocation to the plasma membrane. J. Biol. Chem. 269 (1994) 6089-6092
57. McGeoch J.A., and Irion A.L. The Psychology of Human Learning (1952), Longmans, Green, New York
58. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., AcAllen R.M., Oldfield B.J., Mendelsohn F.A.O., and Chai S.Y. The brain rennin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell. Biol. 35 (2003) 901-918
59. Mehta M.A., and Riedel W.J. Dopaminergic enhancement of cognitive function. Curr. Pharm. Des. 12 (2006) 2487-2500
60. Mendelsohn F.A.O., Jenkins T.A., and Berkovic S.F. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 613 (1993) 221-229
61. Mengold G., Villaró M.T., Landwehrmeyer G.B., Martinez-Mir M.I., Niznik H.B., Sunahara R.K., Seeman P., O'Dowd B.F., Probst A., and Palacios J.M. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem. Int. 20 Suppl. (1992) 33S-43S
62. Meunier M., Bachevalier J., Mishkin M., and Murray E.A. Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J. Neurosci. 13 (1993) 5418-5432
63. Mishkin M., Suzuki W.A., Gadian D.G., and Vargha-Khadem F. Hierarchical organization of cognitive memory. Philos. Trans. R: Soc. Lond. B: Biol. Sci. 352 (1997) 1461-1467
64. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptor: from structure to function. Physiol. Rev. 78 (1998) 189-225
65. Nadel L. The hippocampus and space revisited. Hippocampus 1 (1991) 221-229
66. Newcomer J.W. Metabolic syndrome and mental illness. Am. J. Manag. Care. 13 7 Suppl. (2007) S170-S177
67. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67 (2002) 53-83
68. Pan W., and Kastin A.J. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides. Peptides 28 (2007) 2411-2434
69. Pellow S., Chopin P., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
70. Pierce R.Ch., and Kumaresan V. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 30 (2006) 215-238
71. Previc F.H. Dopamine and the origins of human intelligence. Brain Cogn. 41 (1999) 299-350
72. Quarrel O. The neurobiology of Huntington's disease. In: Harper P.S. (Ed). Huntington Disease (1991), WB Saunders Co. Ltd., London 141-178
73. Randrup A., and Munkvad I. Pharmacology and physiology of stereotyped behaviour. J. Psychiatr. Res. 11 (1974) 1-10
74. Rivera A., Trías S., Peňafiel A., Angel Narváez J., Díaz-Cabiale Z., Moratalla R., and de la Calle A. Expression od D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res. 989 (2003) 35-41
75. Roberts K.A., Krebs L.T., Kramar E.A., Shaffer M.J., Harding J.W., and Wright J.W. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682 (1995) 13-21
76. Robertson M.J. Angiotensin antagonists. In: Leff P. (Ed). Receptor-based Drug Design (1998), Marcel Dekker Inc., New York 207-229
77. Samsonovich A.V., and Nadel L. Fundamental principles and mechanisms of the conscious self. Cortex 41 (2005) 669-689
78. Santos R.A.S., Campagnole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul. Pept. 91 (2000) 45-62
79. 4 receptor binding characteristics: d-amino acid- and glycine-substituted peptides. Peptides 14 (1993) 949-954
80. Seeman P. Dopamine receptors. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press Ltd., New York 295-302
81. Squire L.R. Memory systems of the brain: a brief history and current perspective. Neurobiol. Learn. Mem. 82 (2004) 171-177
82. Stark A.K., and Pakkenberg B. Histological changes of the dopaminergic nigrostriatal system in aging. Cell. Tissue Res. 318 (2004) 81-92
83. Steinlin M. The cerebellum in cognitive processes: supporting studies in children. Cerebellum 6 (2007) 237-241
84. Stragier B., Clinckers R., Meurs A., De Bunel D., Sarre S., Ebinger G., Michotte Y., and Smolders I. Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J. Neurochem. 98 (2006) 1100-1113
85. Stragier B., de Bundel D., Sarre S., Smolders I., Vauquelin G., Dupont A., Michotte Y., and Vanderheyden P. Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Fail. Rev. 13 (2008) 321-337
86. Stragier B., Demaegdt H., De Bundel D., Smolders I., Sarre S., Vauquelin G., Ebinger G., and Michotte Y. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. Brain Res. 1131 (2007) 97-105
87. Stragier B., Sarre S., Vanderheyden P., Vauquelin G., Fournié-Zaluski M.C., Ebinger G., and Michotte Y. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. J. Neurochem. 90 (2004) 1251-1257
88. Tulving E. Multiple learning and memory systems. Psychol. 1990's (1984) 163-184
89. 123I] β-CIT SPECT. Am. J. Psychiatry 161 (2004) 2201-2206
90. Vauquelin G., Michotte Y., Smolders I., Sarre S., Ebinger G., Dupont A., and Vanderheyden P. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. JRAAS 3 (2002) 195-204
91. Voermans N.C., Petersson K.M., Daudey L., Weber B., van Spaendonck K.P., Kremer H.P.H., and Fernández G. Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 43 (2004) 427-435
92. Wang J.M., Baudhuin P., Courtoy P.J., and de Potter W.P. Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture. Endocrinology 136 (1995) 5274-5282
93. Wang J.M., Llona I., and de Potter W.P. Receptor-mediated internalization of angiotensin II in bovine adrenal medullary chromaffin cells in primary culture. Regul. Pept. 53 (1994) 77-86
94. Wayner M.J., Armstrong D.L., Phelix C.F., Wright J.W., and Harding J.W. Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22 (2001) 1403-1414
95. Welches W.R., Santos R.A.S., Chappell M.C., Brosnihan K.B., Greene L.J., and Ferrario C.M. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J. Hypertens. 9 (1991) 631-638
96. White M.N., and Salinas J.A. Mnemonic functions of dorsal striatum and hippocampus in aversive conditioning. Behav. Brain Res. 142 (2003) 99-107
97. Winnicka M.M. Dopaminergic projection to the nucleus accumbens mediates the memory-enhancing effect of angiotensins in rats. Pharmacol. Biochem. Behav. 62 (1999) 625-630
98. Winnicka M.M., Braszko J.J., and Wiśniewski K. 6-OHDA lesions to amygdale and hippocampus attenuate memory-enhancing effect of the 3-7 fragment of angiotensin II. Gen. Pharmacol. 30 (1998) 801-805
99. Wright J.W., and Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioural responses. Neurosci. Biobehav. Rev. 18 1 (1994) 21-53
100. Wright J.W., and Harding J.W. Important roles for angiotensin III and IV in the brain rennin-angiotensin system. Brain Res. Rev. 25 (1997) 96-124
101. Wright J.W., and Harding J.W. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Progress Neurobiol. 72 (2004) 263-293
102. Wright J.W., Yamamoto B.J., and Harding J.W. Angiotensin receptor subtype mediated physiologies and behaviours: new discoveries and clinical targets. Prog. Neurobiol. 84 (2008) 157-181
103. Xiang L., Szebeni K., Szebeni A., Klimek V., Stockmeier C.A., Karolewicz B., Kalbfleisch J., and Ordway G.A. Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression. Brain Res. 1207 (2008) 214-224
104. 4 receptor in rats. Neuropsychopharmacology 29 (2004) 1648-1655
105. Zola-Morgan S., and Squire L.R. Neuroanatomy of memory. Annu. Rev. Neurosci. 16 (1993) 547-563
106. Zola-Morgan S., and Squire L.R. The neuropsychology of memory. Parallel findings in humans and nonhuman primates. Ann. N.Y. Acad. Sci. 608 (1990) 434-450